Episode 124: Night Science – Exploring Curiosity and Creativity in Research and Biotech
Where do scientific breakthroughs really begin, and how much space do we leave for curiosity, intuition, and creative thinking along the way?
In this episode, host Elaine Hamm, PhD, is joined by Auni Williams, PhD, a postdoctoral scholar at Penn State University, for a thoughtful and refreshing conversation about “night science.” Together, they explore the idea that behind every polished grant, publication, or protocol is a messier, more human process driven by curiosity, imagination, and the freedom to explore unconventional ideas. From historical examples of scientific breakthroughs to personal stories from the lab, this episode invites listeners to rethink how discovery really happens.
In this episode, you’ll learn:
- What “night science” is and why embracing early, unpolished ideas is critical for innovation and discovery.
- How modern research culture can unintentionally suppress creativity – and what institutions and leaders can do to protect exploratory thinking.
- Why communicating science as a human, curiosity-driven process is essential for engaging both scientists and the public.
Tune in to learn how making space for curiosity, creativity, and night science can reignite passion for research and lead to the next generation of scientific breakthroughs.
Links:
Connect with Auni Williams, PhD, and learn more about Penn State University.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Learn more about François Jacob, Barry Marshall, August Kekulé, Operation Everest, American Heart Association Funding, and Cormac McCarthy’s essay.
Listen to our previous episode with Walter Isaacson.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Learn more about BIO from the BAYOU – the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.
